LivaNova Balance Sheet
NASDAQ: LIVNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LivaNova financial position
At the end of fiscal 2025, LivaNova reported total assets of $2.61 billion, up 4.0% from a year earlier against total liabilities of $1.41 billion. Shareholders' equity stood at $1.20 billion, or 46.0% of assets. The company held $635.6 million in cash and equivalents against $376.7 million of debt, a net cash position of $258.9 million.
The current ratio (current assets divided by current liabilities) was 1.36, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.31.
Summary generated from market data by MetaCap's automated system. Methodology
LivaNova balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 635.55M | 428.86M | 266.50M | 214.17M | 207.99M | 252.83M | 61.14M | 47.20M | 93.61M | 39.79M |
| Receivables | 215.99M | 193.16M | 215.07M | 183.11M | 185.35M | 184.36M | 257.77M | 256.13M | 282.14M | 213.26M |
| Inventory | 164.70M | 147.57M | 147.89M | 129.38M | 105.84M | 115.28M | 164.15M | 153.53M | 144.47M | 133.02M |
| Total Current Assets | 1.10B | 1.13B | 988.16M | 886.14M | 679.18M | 708.04M | 549.44M | 533.30M | 869.86M | 812.69M |
| Property, Plant & Equipment | 242.60M | 170.26M | 154.18M | 147.19M | 150.07M | 163.81M | 181.35M | 191.40M | 192.36M | 203.71M |
| Goodwill | 792.84M | 750.01M | 782.94M | 768.79M | 899.52M | 922.32M | 915.79M | 956.82M | 784.24M | 691.71M |
| Intangible Assets | 229.96M | 237.29M | 261.18M | 368.56M | 399.68M | 437.64M | 607.55M | 770.44M | 446.40M | 609.20M |
| Long-Term Investments | 20.29M | 25.08M | — | — | — | — | — | — | — | — |
| Total Assets | 2.61B | 2.51B | 2.43B | 2.29B | 2.20B | 2.40B | 2.41B | 2.55B | 2.50B | 2.34B |
| Accounts Payable | 97.16M | 69.73M | 80.84M | 74.31M | 68.00M | 73.67M | 85.89M | 76.73M | 85.92M | 71.93M |
| Short-Term Debt | 31.47M | 78.00M | 18.11M | 23.43M | 229.67M | 13.34M | 77.40M | 28.79M | 84.03M | 47.65M |
| Total Current Liabilities | 808.07M | 392.13M | 334.98M | 297.40M | 696.97M | 309.05M | 512.55M | 496.75M | 406.02M | 349.89M |
| Long-Term Debt | 345.19M | 549.62M | 568.54M | 518.07M | 9.85M | 642.30M | 260.33M | 139.54M | 61.96M | 75.22M |
| Total Liabilities | 1.41B | 1.19B | 1.15B | 1.09B | 906.31M | 1.29B | 1.03B | 1.05B | 688.58M | 635.72M |
| Shareholders' Equity | 1.20B | 1.32B | 1.28B | 1.21B | 1.29B | 1.11B | 1.38B | 1.50B | 1.82B | 1.71B |
| Retained Earnings | -1.15B | -903.25M | -966.48M | -984.03M | -897.78M | -761.97M | -406.75M | -251.58M | -39.66M | -14.57M |
| Total Debt | 376.66M | 627.63M | 586.65M | 541.50M | 239.52M | 655.64M | 337.73M | 168.33M | 145.99M | 122.86M |
| Net Cash (Debt) | 258.89M | -198.77M | -320.15M | -327.33M | -31.53M | -402.81M | -276.59M | -121.13M | -52.38M | -83.08M |
| Shares Outstanding | 54.65M | 54.35M | 53.92M | 53.56M | 53.26M | 48.66M | 48.44M | 48.21M | 48.29M | 48.03B |
This table shows 10 annual periods of LivaNova's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow LIVN's reporting calendar. What is a balance sheet?